EuroNanoMed is a platform for funding agencies and ministries established since 2008. National and Regional research funding programmes join together with the goal of creating and funding collaborative research and innovation projects that can convert research in nanotechnology into practical gains in medicine. EuroNanoMed supports multidisciplinary and translational research and innovation projects that cover: Regenerative medicine, Diagnostics and Targeted delivery systems. EuroNanoMed III (2016-2021) is the new ERA-Net Cofund Action on Nanomedicine under Horizon 2020 that will build upon the achievements on its predecessors to support the European Nanomedicine research community.
EuroNanoMed has thus far allocated about €55M to fund 60 transnational projects in nanomedicine. In this 8th EuroNanoMed call 126 eligible pre-proposals were submitted. A total of 58 peer reviewers from 19 different countries participated in the evaluation process. Based on the peer reviewers’ scores, recommendations and the availability of funds from the participating funding organisations, the Call Steering Committee decided to request a full proposal from 39 consortia. The total available budget for this call was €14M.
Call launched on November 14th 2016 with an expression of interest (EoI) deadline of December 30th 2016. This call is now closed.
For more information please see the EuroNanoMed website.